Skip to main content
    C

    CONMED Corporation (CNMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $49.35
    -1.24 (-2.45%)

    Market Cap: $1.51B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CONMED Corporation (CNMD) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in US dollars.

    CONMED reported revenue of $1.37B for the fiscal year ended Dec 31, 2025, up 5.2% from the year before. That year, net income was $47.05M with a net margin of 3.4%, operating cash flow was $170.69M and free cash flow was $150.88M. The quarter ended Sep 30, 2026 had revenue of $335.56M and net income of $19.80M.

    Revenue and Margins

    The operating margin was 7.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $763.52M, a compound annual rate of 6.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.37B+5.2%54.6%7.5%3.4%
    Dec 2024$1.31B+5.0%56.1%15.3%10.1%
    Dec 2023$1.24B+19.1%54.3%9.7%5.2%
    Dec 2022$1.05B+3.4%54.6%6.7%-7.7%
    Dec 2021$1.01B+17.2%56.2%10.9%6.2%
    Dec 2020$862.46M-9.7%53.4%5.3%1.1%
    Dec 2019$955.10M+11.1%54.9%8.3%3.0%
    Dec 2018$859.63M+7.9%54.6%8.3%4.8%
    Dec 2017$796.39M+4.3%54.1%5.9%7.0%
    Dec 2016$763.52MN/A53.5%4.9%1.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 64.5% from the year before. In the quarter ended Sep 2026, net income rose 592.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.37B$1.31B$1.24B$1.05B$1.01B$862.46M$955.10M$859.63M$796.39M$763.52M
    Cost of revenue$624.25M$573.98M$568.50M$474.23M$442.60M$402.16M$430.38M$390.52M$365.35M$355.19M
    Gross profit$750.48M$733.03M$676.25M$571.25M$568.04M$460.30M$524.72M$469.11M$431.04M$408.33M
    Research and development$55.88M$54.43M$52.60M$47.15M$43.56M$40.47M$45.46M$42.19M$32.31M$32.25M
    Operating income$102.62M$200.33M$120.60M$70.05M$109.72M$46.01M$79.11M$71.31M$46.94M$37.68M
    Net income$47.05M$132.42M$64.46M-$80.58M$62.54M$9.52M$28.62M$40.85M$55.49M$14.66M
    EBITDA$182.13M$277.88M$198.53MN/A$193.28M$131.69M$158.00M$133.11M$105.48M$90.04M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$335.56M$343.49M$317.05M$373.20M$337.93M$342.35M$321.26M$345.94M$316.70M$332.10M$312.27M$327.05M
    Gross profit$189.15M$197.46M$183.45M$218.28M$166.12M$188.32M$177.75M$198.34M$179.00M$183.73M$171.97M$182.18M
    Operating income$37.14M$36.41M$25.41M$36.62M$11.88M$38.16M$15.96M$52.50M$65.71M$47.11M$35.01M$50.19M
    Net income$19.80M$23.07M$13.83M$16.74M$2.86M$21.42M$6.04M$33.75M$48.98M$29.98M$19.71M$33.07M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $834.94M exceeded cash and equivalents by $794.13M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$2.33B$2.31B$2.30B$2.30B$1.77B$1.75B$1.78B$1.37B$1.36B$1.33B
    Current assets$672.86M$640.01M$615.65M$581.23M$460.12M$416.65M$397.36M$374.35M$356.78M$330.51M
    Cash and equivalents$40.82M$24.46M$24.30M$28.94M$20.85M$27.36M$25.86M$17.51M$32.62M$27.43M
    Total liabilities$1.29B$1.34B$1.47B$1.55B$980.58M$1.04B$1.06B$706.87M$726.53M$748.41M
    Short-term debt$712.00K$715.00K$708.00K$69.75M$12.25M$18.41M$13.60M$18.34M$14.70M$10.20M
    Long-term debt$834.23M$905.07M$973.14M$985.08M$672.41M$735.22M$755.21M$438.56M$471.74M$488.29M
    Shareholder equity$1.03B$962.68M$834.22M$745.54M$785.43M$709.04M$710.47M$662.27M$631.43M$580.58M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.30B$2.30B$2.31B$2.33B$2.32B$2.33B$2.30B$2.31B$2.32B$2.29B$2.31B$2.30B
    Total liabilities$1.24B$1.26B$1.30B$1.29B$1.31B$1.33B$1.32B$1.34B$1.38B$1.40B$1.45B$1.47B
    Cash and equivalents$47.97M$37.33M$35.03M$40.82M$38.93M$33.94M$35.48M$24.46M$38.47M$28.87M$33.85M$24.30M
    Shareholder equity$1.06B$1.04B$1.02B$1.03B$1.01B$1.00B$977.64M$962.68M$932.90M$881.83M$854.66M$834.22M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 88.4% of operating cash flow. Dividends came to 16.4% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$170.69M$166.97M$125.35M$33.37M$111.77M$64.53M$95.13M$74.70M$65.57M$39.88M
    Capital expenditures$19.81M$13.08M$19.03M$21.79M$14.87M$13.01M$20.07M$16.51M$12.84M$14.75M
    Free cash flow$150.88M$153.88M$106.32M$11.58M$96.90M$51.52M$75.07M$58.19M$52.72M$25.13M
    Dividends paid$24.75M$24.65M$24.50M$23.96M$23.26M$22.82M$22.60M$22.44M$22.31M$22.21M
    Share repurchasesN/AN/AN/A$69.53M$0$0N/AN/AN/AN/A
    Investing cash flow-$20.96M-$13.08M-$20.03M-$249.53M-$14.87M-$13.64M-$387.66M-$16.51M-$29.05M-$266.02M
    Financing cash flow-$135.82M-$151.00M-$110.43M$225.00M-$101.55M-$52.06M$300.88M-$72.27M-$34.88M$182.54M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$49.41M$37.09M$13.47M$46.34M$53.69M$29.13M$41.53M$43.34M$51.20M$43.31M$29.12M$56.40M
    Capital expenditures$2.68M$2.93M$2.89M$5.11M$5.19M$5.73M$3.78M$4.04M$3.42M$3.59M$2.04M$4.86M
    Free cash flow$46.73M$34.16M$10.58M$41.22M$48.50M$23.41M$37.76M$39.30M$47.78M$39.72M$27.09M$51.54M
    Last 12 quarters

    Frequently Asked Questions About CNMD

    What is CONMED's annual revenue?

    CONMED reported revenue of $1.37B for the fiscal year ended Dec 31, 2025.

    How fast is CONMED's revenue growing?

    Revenue was up 5.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.6%.

    Is CONMED profitable?

    Yes. CONMED reported net income of $47.05M for the fiscal year ended Dec 31, 2025, with a net margin of 3.4%.

    How much free cash flow does CNMD generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $170.69M minus capital expenditures of $19.81M produced free cash flow of $150.88M.

    How much debt does CONMED have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $834.23M, short-term debt of $712.00K and cash and equivalents of $40.82M.